arginyl-glycyl-aspartic acid and Carcinoma, Giant Cell

arginyl-glycyl-aspartic acid has been researched along with Carcinoma, Giant Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chambers, AF; Farina, AR; Gulino, A; Mackay, AR; Sciortino, G; Tacconelli, A; Teti, A; Tiberio, A; Villanova, I	1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Carcinoma, Giant Cell

Article	Year
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent. International journal of cancer, 1998, Jul-03, Volume: 77, Issue:1 Topics: Carcinoma, Giant Cell; Cell Size; Enzyme Activation; Gelatinases; Gene Expression Regulation, Neoplastic; Humans; Integrin-Binding Sialoprotein; Matrix Metalloproteinase 2; Metalloendopeptidases; Oligopeptides; Osteopontin; Sialoglycoproteins; Tumor Cells, Cultured	1998

Article

Year

Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent.

International journal of cancer, 1998, Jul-03, Volume: 77, Issue:1

Topics: Carcinoma, Giant Cell; Cell Size; Enzyme Activation; Gelatinases; Gene Expression Regulation, Neoplastic; Humans; Integrin-Binding Sialoprotein; Matrix Metalloproteinase 2; Metalloendopeptidases; Oligopeptides; Osteopontin; Sialoglycoproteins; Tumor Cells, Cultured

1998